Physical Therapist West Hollywood Joel Scherr Physical Therapy West Hollywood http://www.joelscherrpt.com We are a physical therapist owned clinic in the West Hollywood area. We specialize in the treatment of orthopedic problems including neck, back, shoulder, knee, hip, ankle, elbow and wrist pain and diagnoses. We accept most insurance plans. The best way to find out about your insurance coverage is to give us a call. We are conveniently located in the Ciders-Sinai medical towers at Joel Scherr Physical Therapy 8635 West 3rd Street Los Angeles, CA 90048 310.657.8591 Physical therapy is a great way to address aches and pains. It is conservative, has little to no side effects and compared to drugs, injections and surgery, it is the best 1st choice. Call us today Physical therapy West HollywoodFrom:Joel ScherrViews:0 0ratingsTime:00:51More inPeople Blogs Originally posted here: Physical Therapist West Hollywood - Video … Continue reading →

Channel 4 Adverts 2008 Adverts for Strongbow, T-Mobile, "Essex, Drugs Rock'n' Roll", Garnier, Pantene, Knock Off Nigel, HMV, Mini.From:TVajbViews:1 0ratingsTime:03:34More inEntertainment See original here: Channel 4 Adverts 2008 - Video … Continue reading →

Wizard Test DRUG ABUSE IS A SERIOUS ISSUE IF YOU OR ANYONE YOU KNOW IS ABUSING DRUGS TELL SOMEONE OR CALL 1-800-521-7128From:Ciara KilburnViews:0 0ratingsTime:04:05More inEntertainment Read this article: Wizard Test - Video … Continue reading →

Drug smugglers continue to show creativity in inventing new ways of getting drugs across the U.S. border from Mexico. Border Patrol agents say they believe a pneumatic cannon was used to launch dozens of containers of marijuana over the border and 500 feet into Arizona on Friday. Eighty-five pounds of marijuana -- tucked into soup cans and then inserted into larger sealed containers -- were found in a field near the Colorado River in San Luis, Arizona. After searching the surrounding area, agents spotted the carbon dioxide tank used to power the cannon that propelled the containers into U.S. territory. The smugglers launched the drug-filled projectiles from a position in a brushy area immediately south of the border fence. According to authorities, an accomplice was probably supposed to collect the containers but did not show up in time. The contraband was discovered by a concerned citizen in a plowed field just northwest of San Luis before the U.S counterpart could collect it. After the Border Patrol was notified and searched the field, Mexican authorities also inspected their side of the border, but no arrests have been made. "Because of our progress in targeting and obstructing movement, they can no longer … Continue reading →

NEW YORK, Dec. 12, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Targeted Cancer Drugs The Launch Landscape to 2018 http://www.reportlinker.com/p0777914/Targeted-Cancer-Drugs-The-Launch-Landscape-to-2018 .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication As the cancer therapy market evolves, interest is growing in novel approaches which may supersede the current portfolio. In the short term, the market will be dominated by established therapeutic approaches, but the question is "What next?" A sign of things to come? The end of 2011 saw the US approval of two new molecularly-targeted cancer drugs, alongside companion diagnostic tests that identify the patients most likely to benefit from treatment. Pfizer's Xalkori (crizotinib) and Roche's Zelboraf (vemurafenib) were both approved following a priority review, highlighting the importance that the FDA has placed on hastening the passage of these therapies to market. These approvals reflect the trend of treating cancers based on their molecular and genetic characteristics, rather than their location within the body. Such developments have long been heralded as marking the future of cancer therapies and the benefits to patients, clinicians and health payers is clear but are these approvals the benchmark for future developments? With sales of many blockbuster drugs being cannibalised by generic competitors, pharmaceutical and … Continue reading →